| Q34410537 | 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption |
| Q37246355 | Age-related changes in arthritis susceptibility and severity in a murine model of rheumatoid arthritis |
| Q36638222 | Amelioration of arthritis through mobilization of peptide-specific CD8+ regulatory T cells |
| Q54214340 | Annexin A1 and Autoimmunity: From Basic Science to Clinical Applications. |
| Q28304897 | Annexin A1 and glucocorticoids as effectors of the resolution of inflammation |
| Q38872112 | Arthritis models: usefulness and interpretation |
| Q53082574 | B cell resistance to Fas-mediated apoptosis contributes to their ineffective control by regulatory T cells in rheumatoid arthritis. |
| Q27306863 | Beneficial role of rapamycin in experimental autoimmune myositis |
| Q35769049 | Cells of the synovium in rheumatoid arthritis. T lymphocytes. |
| Q88788977 | Collagen-induced arthritis in Dark Agouti rats as a model for study of immunological sexual dimorphisms in the human disease |
| Q42571975 | Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis |
| Q84312844 | Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment |
| Q56896192 | Depletion of regulatory T cells in a hapten-induced inflammation model results in prolonged and increased inflammation driven by T cells |
| Q35907743 | Depletion of regulatory T cells leads to an exacerbation of delayed-type hypersensitivity arthritis in C57BL/6 mice that can be counteracted by IL-17 blockade |
| Q80545112 | Distinct in vivo roles of CD80 and CD86 in the effector T-cell responses inducing antigen-induced arthritis |
| Q35127503 | Dynamic Frequency of Blood CD4+CD25+ Regulatory T Cells in Rats with Collagen-induced Arthritis |
| Q37868325 | Effector T cells in rheumatoid arthritis: lessons from animal models |
| Q58864639 | Efficacy of regulatory T-cell immunotherapy: are inflammatory cytokines key determinants? |
| Q38161794 | Emerging cell and cytokine targets in rheumatoid arthritis |
| Q39158358 | Engineered regulatory T cells coexpressing MHC class II:peptide complexes are efficient inhibitors of autoimmune T cell function and prevent the development of autoimmune arthritis |
| Q24299602 | FOXP3 ensembles in T-cell regulation |
| Q33695905 | Flt3-L increases CD4+CD25+Foxp3+ICOS+ cells in the lungs of cockroach-sensitized and -challenged mice |
| Q34563552 | Fms-like tyrosine kinase 3 ligand controls formation of regulatory T cells in autoimmune arthritis |
| Q41183700 | FoxP3 and Bcl-xL cooperatively promote regulatory T cell persistence and prevention of arthritis development |
| Q90265133 | Foxp3+ Regulatory T Cells in Bone and Hematopoietic Homeostasis |
| Q87690276 | Ginsenoside metabolite compound k alleviates adjuvant-induced arthritis by suppressing T cell activation |
| Q58780906 | High Interleukin-37 (IL-37) Expression and Increased Mucin-Domain Containing-3 (TIM-3) on Peripheral T Cells in Patients with Rheumatoid Arthritis |
| Q92404720 | Human Memory Th17 Cell Populations Change Into Anti-inflammatory Cells With Regulatory Capacity Upon Exposure to Active Vitamin D |
| Q35907840 | IL-10 signaling in CD4+ T cells is critical for the pathogenesis of collagen-induced arthritis |
| Q38113210 | Immunology and bone |
| Q38120159 | Immunomodulating effects of epigallocatechin-3-gallate from green tea: mechanisms and applications. |
| Q38206949 | Immunomodulation in human and experimental arthritis: including vitamin D, helminths and heat-shock proteins. |
| Q34460609 | Immunomodulation of Autoimmune Arthritis by Herbal CAM |
| Q36298357 | Impaired thymic export and increased apoptosis account for regulatory T cell defects in patients with non-ST segment elevation acute coronary syndrome |
| Q40164249 | In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice. |
| Q59329572 | Induction of chronic destructive arthritis in SCID mice by arthritogenic fibroblast-like synoviocytes derived from mice with antigen-induced arthritis |
| Q43174362 | Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+CD25+ regulatory T cells |
| Q28083298 | Manipulating regulatory T cells: a promising strategy to treat autoimmunity |
| Q34206282 | Mice deficient in CD38 develop an attenuated form of collagen type II-induced arthritis |
| Q42210265 | Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo |
| Q37626412 | Osteoimmunology and the effects of the immune system on bone |
| Q37544448 | Osteoimmunology: crosstalk between the immune and bone systems |
| Q36800150 | Phenotypic, Functional, and Gene Expression Profiling of Peripheral CD45RA+ and CD45RO+ CD4+CD25+CD127(low) Treg Cells in Patients With Chronic Rheumatoid Arthritis |
| Q52657749 | Platforms for Single-Cell Collection and Analysis. |
| Q82076756 | Regulatory T cells in rheumatoid arthritis |
| Q35872027 | Regulatory T cells protect from autoimmune arthritis during pregnancy |
| Q36068905 | Regulatory T cells use programmed death 1 ligands to directly suppress autoreactive B cells in vivo |
| Q36563537 | Regulatory T-cell physiology and application to treat autoimmunity |
| Q37914338 | Regulatory T-cells in systemic lupus erythematosus and rheumatoid arthritis |
| Q37150812 | Role of regulatory T cells in a new mouse model of experimental autoimmune myositis |
| Q24816917 | Role of regulatory T cells in experimental arthritis and implications for clinical use. |
| Q53580597 | Rosmarinic acid induces apoptosis of activated T cells from rheumatoid arthritis patients via mitochondrial pathway. |
| Q57591281 | Silica-coated solid lipid nanoparticles enhance antioxidant and antiradical effects of meloxicam |
| Q38167815 | T regulatory cells in childhood arthritis--novel insights |
| Q51006330 | T regulatory cells participate in the control of germinal centre reactions. |
| Q44893873 | Taurine attenuates Streptococcus uberis-induced mastitis in rats by increasing T regulatory cells |
| Q24633549 | The PD-1 pathway in tolerance and autoimmunity |
| Q36065125 | The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse |
| Q90268330 | The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets |
| Q46046855 | The effect of various disease-modifying anti-rheumatic drugs on the suppressive function of CD4⁺CD25⁺ regulatory T cells |
| Q37784385 | The yin and yang of regulatory T cells and inflammation in RA. |
| Q37632472 | Translational mini-review series on Th17 cells: CD4 T helper cells: functional plasticity and differential sensitivity to regulatory T cell-mediated regulation |
| Q37750140 | Treating arthritis by immunomodulation: is there a role for regulatory T cells? |
| Q83790490 | Type I IFN protects against antigen-induced arthritis |